Literature DB >> 12470255

Applications of SHAPES screening in drug discovery.

Christopher A Lepre1, Jeffrey Peng, Jasna Fejzo, Norzehan Abdul-Manan, Jennifer Pocas, Marc Jacobs, Xiaoling Xie, Jonathan M Moore.   

Abstract

The SHAPES strategy combines nuclear magnetic resonance (NMR) screening of a library of small drug-like molecules with a variety of complementary methods, such as virtual screening, high throughput enzymatic assays, combinatorial chemistry, X-ray crystallography, and molecular modeling, in a directed search for new medicinal chemistry leads. In the past few years, the SHAPES strategy has found widespread utility in pharmaceutical research. To illustrate a variety of different implementations of the method, we will focus in this review on recent applications of the SHAPES strategy in several drug discovery programs at Vertex Pharmaceuticals.

Mesh:

Substances:

Year:  2002        PMID: 12470255     DOI: 10.2174/1386207023329950

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  10 in total

1.  Determining the optimal size of small molecule mixtures for high throughput NMR screening.

Authors:  Kelly A Mercier; Robert Powers
Journal:  J Biomol NMR       Date:  2005-03       Impact factor: 2.835

2.  Protein farnesyltransferase-catalyzed isoprenoid transfer to peptide depends on lipid size and shape, not hydrophobicity.

Authors:  Thangaiah Subramanian; Suxia Liu; Jerry M Troutman; Douglas A Andres; H Peter Spielmann
Journal:  Chembiochem       Date:  2008-11-24       Impact factor: 3.164

3.  Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics.

Authors:  Wan F Lau; Jane M Withka; David Hepworth; Thomas V Magee; Yuhua J Du; Gregory A Bakken; Michael D Miller; Zachary S Hendsch; Venkataraman Thanabal; Steve A Kolodziej; Li Xing; Qiyue Hu; Lakshmi S Narasimhan; Robert Love; Maura E Charlton; Samantha Hughes; Willem P van Hoorn; James E Mills
Journal:  J Comput Aided Mol Des       Date:  2011-05-21       Impact factor: 3.686

4.  A small-molecule probe induces a conformation in HIV TAR RNA capable of binding drug-like fragments.

Authors:  Amy Davidson; Darren W Begley; Carmen Lau; Gabriele Varani
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

Review 5.  High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.

Authors:  Bainan Wu; Elisa Barile; Surya K De; Jun Wei; Angela Purves; Maurizio Pellecchia
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

Review 6.  Perspectives on NMR in drug discovery: a technique comes of age.

Authors:  Maurizio Pellecchia; Ivano Bertini; David Cowburn; Claudio Dalvit; Ernest Giralt; Wolfgang Jahnke; Thomas L James; Steve W Homans; Horst Kessler; Claudio Luchinat; Bernd Meyer; Hartmut Oschkinat; Jeff Peng; Harald Schwalbe; Gregg Siegal
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

7.  Identification of a hydrophobic cleft in the LytTR domain of AgrA as a locus for small molecule interactions that inhibit DNA binding.

Authors:  Paul G Leonard; Ian F Bezar; David J Sidote; Ann M Stock
Journal:  Biochemistry       Date:  2012-12-03       Impact factor: 3.162

8.  Perspectives of biomolecular NMR in drug discovery: the blessing and curse of versatility.

Authors:  Wolfgang Jahnke
Journal:  J Biomol NMR       Date:  2007-08-15       Impact factor: 2.582

Review 9.  NMR-based approaches for the identification and optimization of inhibitors of protein-protein interactions.

Authors:  Elisa Barile; Maurizio Pellecchia
Journal:  Chem Rev       Date:  2014-04-08       Impact factor: 60.622

Review 10.  Capter 11 Filtering in Drug Discovery.

Authors:  Christopher A Lipinski
Journal:  Annu Rep Comput Chem       Date:  2005-10-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.